Phreesia Named to The Software Report’s “Top 100 Software Companies” for the Third Consecutive Year

Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year.

Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.

Amprion Announces Landmark Study in The Lancet Neurology

Novel synSAA Advances Diagnostic Accuracy for Multiple System Atrophy and Related Disorders

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

eClinical Solutions Positioned as Highest Leader in Everest Group’s Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024

Industry recognition highlights company’s diverse portfolio mix, flexibility and ease of deployment, and data integration capabilities, driving real-time review and insights

CIRCOR’s Highlights BB PEP Series Pumps for Polymer Extrusion

CIRCOR International, Inc., a leading manufacturer and marketer of differentiated technology products and sub-systems, highlights its new BB PEP Series pumps, engineered for high-precision performance in polymer extrusion applications. With a focus on consistent, accurate performance, the BB PEP Series addresses critical demands such as uniformity, durability, and ease of maintenance in the chemical, industrial and life sciences industries.

Beta Bionics Secures $60 Million in Series E Funding to Advance Diabetes Care Innovations

In November 2024, a $60 million fundraising transaction for Series E preferred stock was successfully closed by Beta Bionics, Inc., a trailblazing leader in the creation of cutting-edge diabetes treatment solutions.

Creative Biolabs Vaccine Solutions: Jumping into Action to Take on Monkeypox

With the global fight against the monkeypox epidemic intensifying, Creative Biolabs has risen to the occasion by introducing a comprehensive monkeypox virus vaccine development strategy.

SUNRISE LABS CONGRATULATES SAMAY, WINNER OF MEDTECH INNOVATOR 2024 GRAND PRIZE, AND CELEBRATES MENTORSHIP ROLE

Sunrise Labs celebrates Samay, winner of the 2024 MedTech Innovator Grand Prize, for their groundbreaking COPD solution. As a sponsor and mentor, we support innovation that transforms healthcare. Learn more about this achievement and our commitment to advancing medical technology.

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight1 Image Management System (IMS), today announced the integration of several AI products from market leading digital pathology companies, including Deep Bio, DoMore Diagnostics, Paige, and Visiopharm. Through these collaborations, PathAI will provide algorithms from these developers directly within its AISight IMS, reinforcing its commitment to offering the most versatile, reliable, and interoperable IMS on the market.

Endor Labs Collaborates with Microsoft Defender for Cloud to Create Industry’s First Code-to-Runtime Reachability in a CNAPP

Endor Labs today announced that Microsoft has natively integrated its Software Composition Analysis (SCA) solution into Defender for Cloud, creating the industry’s first code-to-runtime reachability in a Cloud-Native Application Protection Platform (CNAPP). The integration empowers organizations to consolidate their application security and cloud security programs into a single platform, securing cloud workloads and code in one place. They can deploy SCA and CNAPP solutions from a unified dashboard, and achieve comprehensive security coverage from code to runtime.

Illumina Rolls out MiSeq i100 Series to Reshape Next-Generation Sequencing

The MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.

Sapio Sciences Collaborates with Waters Corporation to Improve Efficiency of Laboratory Operations

Sapio Sciences, the science-aware™ lab informatics platform, today announced it has entered a co-marketing agreement with Waters Corporation to enhance data integrity, workflow efficiency, and laboratory productivity

Cotiviti to Launch End-to-End Healthcare Fraud Solution at 2024 NHCAA Annual Training Conference

Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses

Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.

Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients

Owkin’s MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of Proscia’s precision medicine AI portfolio.

Future Fields Debuts Instar 1.0: A Biofactory With 30 Times the Output of Conventional Protein Technology

Recombinant protein biomanufacturer debuts factory and new product line

Oregon Freeze Dry Brings in New Leadership

Life Sciences CDMO Veteran David Enloe Appointed CEO of OFD.

City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics

City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.

Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.